Inspire Medical Systems (INSP) Price & Analysis

Compare

808 Followers

INSP Stock Chart & Stats

$66.33

-$1.46(-0.68%)

At close: Jan 08 4:00 PM EST

$66.33

-$1.46(-0.68%)

Day’s Range― - ―

52-Week Range$64.46 - $197.75

Previous CloseN/A

Volume95.34K

Average Volume (3M)1.15M

Market Cap

$1.98B

Enterprise Value$1.69B

Total Cash (Recent Filing)$322.59M

Total Debt (Recent Filing)$32.58M

Price to Earnings (P/E)45.5

Beta0.39

Next Earnings

May 05, 2026

EPS Estimate

-0.18

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.65

Shares Outstanding29,056,435

10 Day Avg. Volume1,139,266

30 Day Avg. Volume1,146,629

Financial Highlights & Ratios

PEG Ratio-0.29

Price to Book (P/B)8.00

Price to Sales (P/S)6.87

P/FCF Ratio60.55

Enterprise Value/Market Cap0.85

Enterprise Value/Revenue1.92

Enterprise Value/Gross Profit2.26

Enterprise Value/Ebitda22.07

Forecast

1Y Price Target

$104.50

Price Target Upside57.55% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering18

EPS Forecast (FY)1.76

Revenue Forecast (FY)$1.01B

Bulls Say, Bears Say

Bulls Say

Analyst Valuation OutlookAnalyst increased the price target to $128 following favorable reimbursement news, signaling improved investor confidence in the company's trajectory.

Patient Volume TailwindsPatient warehousing shifting into a tailwind combined with increased advertising is expected to drive higher patient volumes and procedure uptake.

Pricing PowerAnalyst expects an anticipated material price increase to lift average revenue per procedure and support company top-line growth.

Bears Say

Operational Rollout ConstraintsCapacity utilization bottlenecks and a slower than expected I-5 rollout could constrain procedure throughput and delay realization of revenue growth.

Physician Reimbursement RiskA reimbursement code change that employs a modifier can materially reduce physician payments, undermining provider incentives to recommend the procedure.

Regional Coverage UncertaintyRemoval of obstructive sleep apnea as a covered diagnosis for CPT 64568 and MAC-level decision making creates inconsistent coverage and uneven reimbursement outcomes across regions.

Inspire Medical Systems News

Shopify upgraded, Coinbase downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

21h ago

ADI

Inspire Medical price target lowered to $68 from $90 at RBC Capital

RBC Capital lowered the firm’s price target on Inspire Medical (INSP) to $68 from $90 and keeps a...

21h ago

INSP

Inspire Medical price target lowered to $95 from $110 at Stifel

Stifel lowered the firm’s price target on Inspire Medical (INSP) to $95 from $110 and keeps a Buy...

22h ago

INSP

Inspire Medical price target lowered to $85 from $165 at Piper Sandler

Piper Sandler lowered the firm’s price target on Inspire Medical (INSP) to $85 from $165 and keeps an...

23h ago

INSP

Inspire Medical price target lowered to $67 from $118 at JPMorgan

JPMorgan lowered the firm’s price target on Inspire Medical (INSP) to $67 from $118 and keeps a Neutral...

23h ago

INSP

Inspire Medical price target lowered to $85 from $130 at Mizuho

Mizuho lowered the firm’s price target on Inspire Medical (INSP) to $85 from $130 and keeps an Outperform...

23h ago

INSP

Inspire Medical downgraded to Hold from Buy at Nephron Research

Nephron Research downgraded Inspire Medical (INSP) to Hold from Buy. Published first on TheFly – the ultimate source...

23h ago

INSP

Inspire Medical downgraded to Equal Weight from Overweight at Wells Fargo

Wells Fargo downgraded Inspire Medical (INSP) to Equal Weight from Overweight with a price target of $70, down...

1d ago

INSP

Inspire Medical downgraded to Neutral from Outperform at Baird

Baird downgraded Inspire Medical (INSP) to Neutral from Outperform with a price target of $74, down from $130....

1d ago

INSP

Closing Bell Movers: Cisco falls 7% after earnings

S&P 500 has continued to flirt with the 7,000 level but, similar to yesterday’s price action, any early-session...

1d ago

Inspire Medical Weighs Growth Against Reimbursement Risks

Inspire Medical (($INSP)) has held its Q4 earnings call. Read on for the main highlights of the call....

11h ago

INSP

Inspire Medical Updates Governance, Outlines 2026 Growth Outlook

Inspire Medical Systems ( ($INSP) ) just unveiled an announcement. Inspire Medical Systems reported on February 11, 2026...

2d ago

INSP

INSP Upcoming Earnings Report: What to Expect?

Inspire Medical (INSP) is scheduled to report 4th quarter earnings on 02/11/2026, after the market closes. Regarding Q4...

4d ago

INSP

Inspire Medical Systems Issues Strong Preliminary 2025 Revenue Results

Inspire Medical Systems ( ($INSP) ) has issued an announcement. On January 12, 2026, Inspire Medical Systems reported...

1M ago

INSP

INSP FAQ

What was Inspire Medical’s price range in the past 12 months?

Inspire Medical lowest stock price was $64.46 and its highest was $197.75 in the past 12 months.

What is Inspire Medical’s market cap?

Inspire Medical’s market cap is $1.98B.

When is Inspire Medical’s upcoming earnings report date?

Inspire Medical’s upcoming earnings report date is May 05, 2026 which is in 81 days.

How were Inspire Medical’s earnings last quarter?

Inspire Medical released its earnings results on Feb 11, 2026. The company reported $1.65 earnings per share for the quarter, beating the consensus estimate of $0.742 by $0.908.

Is Inspire Medical overvalued?

According to Wall Street analysts Inspire Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Inspire Medical pay dividends?

Inspire Medical does not currently pay dividends.

What is Inspire Medical’s EPS estimate?

Inspire Medical’s EPS estimate is -0.18.

How many shares outstanding does Inspire Medical have?

Inspire Medical has 29,056,435 shares outstanding.

What happened to Inspire Medical’s price movement after its last earnings report?

Inspire Medical reported an EPS of $1.65 in its last earnings report, beating expectations of $0.742. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Inspire Medical?

Currently, no hedge funds are holding shares in INSP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Inspire Medical Systems Stock Smart Score

Outperform

Fundamentals

Return on Equity

6.54%

Trailing 12-Months

Asset Growth

1.45%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Inspire Medical

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems (INSP) Earnings & Revenues

Historic Earnings Reports

INSP Company Deck

INSP Earnings Call

Q4 2026

0:00 / 0:00

Earnings Call Sentiment|Neutral

The call presents a balanced picture: strong 2025 financial results, cash generation, buybacks, and clear clinical and commercial traction for Inspire 5 (training, high center adoption, superior clinical metrics). However, material near-term reimbursement and coding uncertainty (transition to CPT 64582 with a -52 modifier), the WISER prior-authorization pilot, and inconsistent claims processing introduce significant short- to medium-term risk that widened 2026 guidance and could constrain physician willingness and early-year procedures. Management has a dual-path remediation plan (short-term payer engagement to reduce the modifier impact and long-term pursuit of a new CPT code), plus product and operational levers, but the timing and magnitude of reimbursement outcomes remain the key risk to achieving the higher end of guidance.View all INSP earnings summaries

INSP Revenue Breakdown

97.02% U.S.

2.98% Other

INSP Stock 12 Month Forecast

Average Price Target

$104.50

▲(57.55% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"66":"$66","98":"$98","130":"$130","162":"$162","194":"$194"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":180,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$180.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":104.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$104.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$67.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[66,98,130,162,194],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,81.64615384615385,89.8423076923077,98.03846153846155,106.23461538461538,114.43076923076924,122.62692307692308,130.82307692307694,139.01923076923077,147.2153846153846,155.41153846153847,163.60769230769233,171.80384615384617,{"y":180,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,75.83846153846154,78.22692307692309,80.61538461538461,83.00384615384615,85.3923076923077,87.78076923076924,90.16923076923078,92.5576923076923,94.94615384615385,97.33461538461539,99.72307692307692,102.11153846153846,{"y":104.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,72.95384615384616,72.45769230769231,71.96153846153847,71.46538461538462,70.96923076923078,70.47307692307693,69.97692307692307,69.48076923076923,68.98461538461538,68.48846153846154,67.99230769230769,67.49615384615385,{"y":67,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":193.5,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.98,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.81,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.51,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.38,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.08,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.34,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.23,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >